Fig. 3
A Pathways significantly upregulated due to Tollip knockout (TKD) compared to control (CTR). B Pathways significantly upregulated in Tollip knockout + IL-13-treated (TKDIL13) compared to IL-13 treatment-only (IL13)
Fig. 3 | BMC Research Notes